Does Whole-Body Hypothermia in Neonates with Hypoxic-Ischemic Encephalopathy Affect Surfactant Disaturated-Phosphatidylcholine Kinetics?

PLoS One. 2016 Apr 12;11(4):e0153328. doi: 10.1371/journal.pone.0153328. eCollection 2016.

Abstract

Background: It is unknown whether Whole-Body Hypothermia (WBH) affects pulmonary function. In vitro studies, at relatively low temperatures, suggest that hypothermia may induce significant changes to the surfactant composition. The effect of WBH on surfactant kinetics in newborn infants is unknown. We studied in vivo kinetics of disaturated-phosphatidylcholine (DSPC) in asphyxiated newborns during WBH and in normothermic controls (NTC) with no or mild asphyxia. Both groups presented no clinically apparent lung disease.

Methods: Twenty-seven term or near term newborns requiring mechanical ventilation were studied (GA 38.6±2.2 wks). Fifteen during WBH and twelve NTC. All infants received an intra-tracheal dose of 13C labelled DSPC and tracheal aspirate were performed. DSPC amount, DSPC half-life (HL) and pool size (PS) were calculated.

Results: DSPC amount in tracheal aspirates was 0.42 [0.22-0.54] and 0.36 [0.10-0.58] mg/ml in WBH and NTC respectively (p = 0.578). DSPC HL was 24.9 [15.7-52.5] and 25.3 [15.8-59.3] h (p = 0.733) and DSPC PS was 53.2 [29.4-91.6] and 40.2 [29.8-64.6] mg/kg (p = 0.598) in WBH and NTC respectively.

Conclusions: WBH does not alter DSPC HL and PS in newborn infants with no clinical apparent lung disease.

MeSH terms

  • Brain Diseases / metabolism
  • Brain Diseases / physiopathology*
  • Female
  • Gestational Age
  • Half-Life
  • Humans
  • Hypothermia / metabolism
  • Hypothermia / physiopathology*
  • Hypoxia-Ischemia, Brain / metabolism
  • Hypoxia-Ischemia, Brain / physiopathology*
  • Infant, Newborn
  • Infant, Premature / metabolism
  • Kinetics
  • Lung / metabolism
  • Lung / physiopathology
  • Male
  • Phosphatidylcholines / metabolism*
  • Prospective Studies
  • Pulmonary Surfactants / metabolism*
  • Respiration, Artificial / methods
  • Surface-Active Agents / metabolism*
  • Trachea / metabolism
  • Trachea / physiopathology

Substances

  • Phosphatidylcholines
  • Pulmonary Surfactants
  • Surface-Active Agents
  • lecithins, disaturated

Grants and funding

The authors have no support or funding to report.